Structured Debt + Equity Investments for Life Sciences Companies

Life Sciences Seminar Series

01/14/2015 08:30 a.m. - 10:00 a.m.

Life Sciences, Business Restructuring + Insolvency, and Financial Transactions

425 Market Street
33rd Floor
San Francisco, CA 94105


Jennifer Dubman
(415) 268-6742

The panel discussion, led by Bill Veatch, will cover the latest debt structures for investing in healthcare companies, including:

  • The types of healthcare companies that lenders are attracted to and why
  • How the loans are structured from a collateral perspective
  • Secured debt versus true sales of royalties
  • Bankruptcy issues in structuring royalty finance transactions, including Section 552 of the Bankruptcy Code


  • Bill Veatch
    Partner, Morrison & Foerster LLP
  • Luke Duster
    Managing Director, CRG LP
  • Larry Engel
    Partner, Morrison & Foerster LLP
  • Catherine Young Hagerty
    Of Counsel, Morrison & Foerster LLP


Breakfast and networking: 8:30 a.m. – 9:00 a.m.

Program: 9:00 a.m. – 10:00 a.m.

Email Disclaimer

Unsolicited e-mails and information sent to Morrison & Foerster will not be considered confidential, may be disclosed to others pursuant to our Privacy Policy, may not receive a response, and do not create an attorney-client relationship with Morrison & Foerster. If you are not already a client of Morrison & Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

©1996-2019 Morrison & Foerster LLP. All rights reserved.